scispace - formally typeset
F

Farangis Ataei

Researcher at Tarbiat Modares University

Publications -  32
Citations -  737

Farangis Ataei is an academic researcher from Tarbiat Modares University. The author has contributed to research in topics: Luciferase & Apoptosis. The author has an hindex of 11, co-authored 28 publications receiving 495 citations.

Papers
More filters
Journal ArticleDOI

MicroRNA-100 shuttled by mesenchymal stem cell-derived exosomes suppresses in vitro angiogenesis through modulating the mTOR/HIF-1α/VEGF signaling axis in breast cancer cells.

TL;DR: The findings suggest that exosomal transfer of miR-100 may be a novel mechanism underlying the paracrine effects of MSC-derived exosomes and may provide a means by which these vesicles can modulate vascular responses within the microenvironment of breast cancer cells.
Journal ArticleDOI

Chitosan Immobilization on Bio-MOF Nanostructures: A Biocompatible pH-Responsive Nanocarrier for Doxorubicin Release on MCF-7 Cell Lines of Human Breast Cancer.

TL;DR: The CS/Bio-MOF carrier greatly enhances cellular uptake of the drug by the MCF-7 cells and, therefore, apoptosis of the cells due to its biocompatibility and pH-responsive behavior.
Journal ArticleDOI

Design and development of a whole-cell luminescent biosensor for detection of early-stage of apoptosis.

TL;DR: This biosensor can be used as a new platform, based on the protein fragment complementation strategy for assessing potential chemotherapeutic drugs as well as a sensitive and dynamic system in the time- and dose-dependent studies of apoptosis.
Journal ArticleDOI

A Luminescent Amine-Functionalized Metal–Organic Framework Conjugated with Folic Acid as a Targeted Biocompatible pH-Responsive Nanocarrier for Apoptosis Induction in Breast Cancer Cells

TL;DR: It is revealed that FOLA@NH2-Eu:TMU-62 carrier could be utilized in accurate cancer treatments through apoptotic pathways with higher reactive oxygen species (ROS) compared with 5-Fu alone.
Journal ArticleDOI

A novel luminescent biosensor for rapid monitoring of IP3 by split-luciferase complementary assay

TL;DR: A novel biosensor based on luciferase fragment assisted complementation strategy, which converts the ligand-induced conformational changes to light and facilitates monitoring of the response of IP(3) in living organisms is described.